172 related articles for article (PubMed ID: 22741536)
21. Effect of valine 106 on structure-function relation of cytosolic human thymidine kinase. Kinetic properties and oligomerization pattern of nine substitution mutants of V106.
Frederiksen H; Berenstein D; Munch-Petersen B
Eur J Biochem; 2004 Jun; 271(11):2248-56. PubMed ID: 15153115
[TBL] [Abstract][Full Text] [Related]
22. Analytical and clinical characterization of an optimized dual monoclonal sandwich ELISA for the quantification of thymidine kinase 1 (TK1) protein in human blood samples.
Jagarlamudi KK; L S; M Z; J O; P V; S E
PLoS One; 2022; 17(10):e0275444. PubMed ID: 36201558
[TBL] [Abstract][Full Text] [Related]
23. Kinetic properties of mutant human thymidine kinase 2 suggest a mechanism for mitochondrial DNA depletion myopathy.
Wang L; Saada A; Eriksson S
J Biol Chem; 2003 Feb; 278(9):6963-8. PubMed ID: 12493767
[TBL] [Abstract][Full Text] [Related]
24. Structures of thymidine kinase 1 of human and mycoplasmic origin.
Welin M; Kosinska U; Mikkelsen NE; Carnrot C; Zhu C; Wang L; Eriksson S; Munch-Petersen B; Eklund H
Proc Natl Acad Sci U S A; 2004 Dec; 101(52):17970-5. PubMed ID: 15611477
[TBL] [Abstract][Full Text] [Related]
25. Comparative active-site mutation study of human and Caenorhabditis elegans thymidine kinase 1.
Skovgaard T; Uhlin U; Munch-Petersen B
FEBS J; 2012 May; 279(10):1777-87. PubMed ID: 22385435
[TBL] [Abstract][Full Text] [Related]
26. Comparative aspects of the proliferation marker thymidine kinase 1 in human and canine tumour diseases.
von Euler H; Eriksson S
Vet Comp Oncol; 2011 Mar; 9(1):1-15. PubMed ID: 21303450
[TBL] [Abstract][Full Text] [Related]
27. Altered kinetic properties of recombinant human cytosolic thymidine kinase (TK1) as compared with the native form.
Jensen HK; Munch-Petersen B
Adv Exp Med Biol; 1994; 370():637-40. PubMed ID: 7660985
[No Abstract] [Full Text] [Related]
28. Characterization of oligomeric and kinetic properties of tomato thymidine kinase 1.
Mutahir Z; Larsen NB; Christiansen LS; Andersson KM; Rico R; Wisen SM; Clausen AR; Munch-Petersen B; Piškur J
Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1223-6. PubMed ID: 22132978
[TBL] [Abstract][Full Text] [Related]
29. Serum thymidine kinase 1 activity as a pharmacodynamic marker of cyclin-dependent kinase 4/6 inhibition in patients with early-stage breast cancer receiving neoadjuvant palbociclib.
Bagegni N; Thomas S; Liu N; Luo J; Hoog J; Northfelt DW; Goetz MP; Forero A; Bergqvist M; Karen J; Neumüller M; Suh EM; Guo Z; Vij K; Sanati S; Ellis M; Ma CX
Breast Cancer Res; 2017 Nov; 19(1):123. PubMed ID: 29162134
[TBL] [Abstract][Full Text] [Related]
30. Deoxyribonucleoside kinases belonging to the thymidine kinase 2 (TK2)-like group vary significantly in substrate specificity, kinetics and feed-back regulation.
Knecht W; Petersen GE; Munch-Petersen B; Piskur J
J Mol Biol; 2002 Jan; 315(4):529-40. PubMed ID: 11812127
[TBL] [Abstract][Full Text] [Related]
31. Elevated serum thymidine kinase activity in canine splenic hemangiosarcoma*.
Thamm DH; Kamstock DA; Sharp CR; Johnson SI; Mazzaferro E; Herold LV; Barnes SM; Winkler K; Selting KA
Vet Comp Oncol; 2012 Dec; 10(4):292-302. PubMed ID: 22236280
[TBL] [Abstract][Full Text] [Related]
32. Reversible tetramerization of human TK1 to the high catalytic efficient form is induced by pyrophosphate, in addition to tripolyphosphates, or high enzyme concentration.
Munch-Petersen B
FEBS J; 2009 Jan; 276(2):571-80. PubMed ID: 19087190
[TBL] [Abstract][Full Text] [Related]
33. Structural and Kinetic Characterization of Thymidine Kinase from Leishmania major.
Timm J; Bosch-Navarrete C; Recio E; Nettleship JE; Rada H; González-Pacanowska D; Wilson KS
PLoS Negl Trop Dis; 2015 May; 9(5):e0003781. PubMed ID: 25978379
[TBL] [Abstract][Full Text] [Related]
34. Highly purified recombinant varicella Zoster virus thymidine kinase is a homodimer.
Amrhein I; Wurth C; Bohner T; Hofbauer R; Folkers G; Scapozza L
Protein Expr Purif; 2000 Apr; 18(3):338-45. PubMed ID: 10733888
[TBL] [Abstract][Full Text] [Related]
35. Thymidine kinase 1 as a tumor biomarker: technical advances offer new potential to an old biomarker.
Jagarlamudi KK; Shaw M
Biomark Med; 2018 Sep; 12(9):1035-1048. PubMed ID: 30039979
[TBL] [Abstract][Full Text] [Related]
36. Tight binding of deoxyribonucleotide triphosphates to human thymidine kinase 2 expressed in Escherichia coli. Purification and partial characterization of its dimeric and tetrameric forms.
Barroso JF; Elholm M; Flatmark T
Biochemistry; 2003 Dec; 42(51):15158-69. PubMed ID: 14690426
[TBL] [Abstract][Full Text] [Related]
37. The clinical significance of thymidine kinase 1 measurement in serum of breast cancer patients using anti-TK1 antibody.
He Q; Zou L; Zhang PA; Lui JX; Skog S; Fornander T
Int J Biol Markers; 2000; 15(2):139-46. PubMed ID: 10883887
[TBL] [Abstract][Full Text] [Related]
38. Binding of ATP to TK1-like enzymes is associated with a conformational change in the quaternary structure.
Segura-Peña D; Lutz S; Monnerjahn C; Konrad M; Lavie A
J Mol Biol; 2007 May; 369(1):129-41. PubMed ID: 17407781
[TBL] [Abstract][Full Text] [Related]
39. Existence of phosphorylated and dephosphorylated forms of cytosolic thymidine kinase (TK1).
He Q; Skog S; Wu C; Johansson A; Tribukait B
Biochim Biophys Acta; 1996 Feb; 1289(1):25-30. PubMed ID: 8605228
[TBL] [Abstract][Full Text] [Related]
40. Liquid chromatography-tandem mass spectrometry method for quantification of thymidine kinase activity in human serum by monitoring the conversion of 3'-deoxy-3'-fluorothymidine to 3'-deoxy-3'-fluorothymidine monophosphate.
Faria M; Halquist MS; Kindt E; Li W; Karnes HT; O'Brien PJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Oct; 907():13-20. PubMed ID: 22995377
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
